Anker, Stefan D.

Anaemia is an independent predictor of poor outcome in patients with chronic heart failure

Szachniewicz, J., Petruk-Kowalczyk, J., Majda, J., Kaczmarek, A., Reczuch, K., Kalra, P. R., Piepoli, M. F., Anker, S. D., Banasiak, W., & Ponikowski, P. (2003) · International Journal of Cardiology

Erythropoietin and Anemia TreatmentHeart Failure Treatment and Management

Cited by 138

Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes

Filippatos, G., Butler, J., Farmakis, D., Zannad, F., Ofstad, A. P., Ferreira, J. P., Green, J. B., Rosenstock, J., Schnaidt, S., Brueckmann, M., et al. (2022) · Circulation

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 131

The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure

Ebner, N., Jankowska, E. A., Ponikowski, P., Lainscak, M., Elsner, S., Sliziuk, V., Steinbeck, L., Kube, J., Bekfani, T., Scherbakov, N., et al. (2016) · International Journal of Cardiology

Erythropoietin and Anemia TreatmentIron Metabolism and Disorders

Cited by 131

Empagliflozin and major renal outcomes in heart failure

Packer, M., Butler, J., Zannad, F., Pocock, S. J., Filippatos, G., Ferreira, J. P., Brueckmann, M., Jamal, W., Zeller, C., Wanner, C., et al. (2021) · New England Journal of Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 112

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone

Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., et al. (2022) · Nephrology Dialysis Transplantation

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 103

Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure

Packer, M., Butler, J., Zeller, C., Pocock, S. J., Brueckmann, M., Ferreira, J. P., Filippatos, G., Usman, M. S., Zannad, F., & Anker, S. D. (2023) · Circulation

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 86

Studies on Intragastric PCO2 at Rest and During Exercise as a Marker of Intestinal Perfusion in Patients with Chronic Heart Failure

Krack, A., Richartz, B. M., Gastmann, A., Greim, K., Lotze, U., Anker, S. D., & Figulla, H. R. (2004) · European Journal of Heart Failure

Abdominal vascular conditions and treatmentsSepsis Diagnosis and Treatment

Cited by 83

Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial

Pandey, A., Patel, K. V., Segar, M. W., Ayers, C., Linge, J., Leinhard, O. D., Anker, S. D., Butler, J., Verma, S., Joshi, P. H., et al. (2024) · Journal of Cachexia, Sarcopenia and Muscle

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 80

Treatment of cachexia: an overview of recent developments

von Haehling, S., & Anker, S. D. (2014) · Journal of the American Medical Directors Association

Nutrition and Health in AgingMuscle Physiology and Disorders

Cited by 79

Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J. V., Wikstrand, J., Anker, S. D., et al. (2019) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 71

Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies

Grote Beverborg, N., van der Wal, H. H., Klip, I. T., Anker, S. D., Cleland, J., Dickstein, K., van Veldhuisen, D. J., Voors, A. A., & van der Meer, P. (2019) · JAMA Cardiology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 65

Association of statin use and clinical outcomes in heart failure patients: A systematic review and meta-analysis

Bielecka-Dabrowa, A., Bytyçi, I., Von Haehling, S., Anker, S., Jozwiak, J., Rysz, J., Hernandez, A. V., Bajraktari, G., Mikhalidis, D. P., & Banach, M. (2019) · Lipids in Health and Disease

Heart Failure Treatment and ManagementLipoproteins and Cardiovascular Health

Cited by 57

Influence of diabetes mellitus and hyperglycemia on prognosis in patients ≥70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS])

de Boer, R. A., Doehner, W., van der Horst, I. C. C., Anker, S. D., Babalis, D., Roughton, M., Coats, A. J., Flather, M. D., & van Veldhuisen, D. J. (2010) · The American Journal of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 39

Obesity and the Heart

von Haehling, S., Doehner, W., & Anker, S. D. (2006) · Journal of the American College of Cardiology

Cardiovascular Function and Risk FactorsCardiovascular Disease and Adiposity

Cited by 22

Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations

Butler, J., Anker, S. D., Filippatos, G., Usman, M. S., Ferreira, J. P., Zannad, F., & Packer, M. (2021) · European Heart Journal

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 18

Muscle Loss in Obesity Therapy as a Therapeutic Target: Trial Design and Endpoints for Regulatory Discussions

von Haehling, S., Sato, R., Langer, H., Khan, M. S., Coats, A. J. S., Evans, W., Heymsfield, S., & Anker, S. D. (2025) · Journal of Cachexia, Sarcopenia and Muscle

Nutrition and Health in AgingPharmacology and Obesity Treatment

Cited by 10

Plasma concentrations of bacterial lipopolysaccharide: a marker of infection or inflammation?

Rauchhaus, M., & Anker, S. D. (2000) · Journal of the American College of Cardiology

Immune Response and InflammationSepsis Diagnosis and Treatment

Cited by 5